Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Bavarian Nordic

Bavarian Nordic

188,35DKK
−0,16% (−0,30)
Päätöskurssi
Ylin191,95
Alin187,55
Vaihto
66,3 MDKK
188,35DKK
−0,16% (−0,30)
Päätöskurssi
Ylin191,95
Alin187,55
Vaihto
66,3 MDKK

Bavarian Nordic

Bavarian Nordic

188,35DKK
−0,16% (−0,30)
Päätöskurssi
Ylin191,95
Alin187,55
Vaihto
66,3 MDKK
188,35DKK
−0,16% (−0,30)
Päätöskurssi
Ylin191,95
Alin187,55
Vaihto
66,3 MDKK

Bavarian Nordic

Bavarian Nordic

188,35DKK
−0,16% (−0,30)
Päätöskurssi
Ylin191,95
Alin187,55
Vaihto
66,3 MDKK
188,35DKK
−0,16% (−0,30)
Päätöskurssi
Ylin191,95
Alin187,55
Vaihto
66,3 MDKK
2025 Q3 -tulosraportti
29 päivää sitten45 min

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
69 002
Myynti
Määrä
69 035

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
8--
76--
1 939--
948--
152--
Ylin
191,95
VWAP
189,04
Alin
187,55
VaihtoMäärä
66,3 350 659
VWAP
189,04
Ylin
191,95
Alin
187,55
VaihtoMäärä
66,3 350 659

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4 -tulosraportti
12.3.2026
Menneet tapahtumat
2025 Q3 -tulosraportti14.11.
2025 Q2 -tulosraportti26.8.
2025 Q1 -tulosraportti9.5.
2024 Q4 -tulosraportti5.3.
2024 Q3 -tulosraportti15.11.2024
Datan lähde: FactSet, Quartr

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    When will the offer of 270 kr. come, which ATP assessed to be an appropriate level for the share when the company was to be sold? The price has been around 190 +/- for almost a month after the rejection of 250 kr.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Well, but if many small shareholders like us contact them, it can also make an impression.
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    It's absolutely incredible what one can read, here from an article in Medwatch: "CEO Paul Chaplin believes in market support if the company needs new capital raising for future acquisitions." Bavarian has currently initiated an acquisition program for 500 mio., and at the same time, the CEO is apparently toying with the idea of capital raising for acquisitions. So the money being paid out to shareholders now, the company might ask to get back later It's of course great for the financial institutions and SKAT that part of the 500 mio. from the acquisition program ends up with them, but where is the consideration for the shareholders??? Just sell that junk.
    1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Johse Share buybacks are for "treasury", if you read the communication from Bavarian. The capital is therefore NOT distributed further to the shareholders but is held by the company. Please ask if you want a more detailed explanation before you draw any wrong conclusions with "payout" and "tax".
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    The criticism below of Bavarian and ATP you should direct towards yourselves. Now be an adult. It is solely us as shareholders who are responsible for our investments, and we should have sold at 230-250 when the opportunity was there.. If we do not trust the company's management or its major shareholder, then we must find something else to invest in. Bavarian's management has always been incompetent, overly optimistic, and untrustworthy. The major shareholder's task is not to look after our interests (that is solely our own task), but his task is to look after the interests of the employees/trade union movement.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Which criticism below, Johse?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Wouldn't it be more relevant to place your "general" criticism in the respective thread another time, instead of arguing into thin air?
  • 2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    Nice to see ATP as a "critical" shareholder and again positive towards Bavarian's management. ATP proves once again to be completely useless as a shareholder, to put its foot down and exercise its power over the management. What does the army in here think, who during the process were positive about ATP's abilities and their no to a sale. Did you expect that ATP would subsequently explicitly support the management and again be positive about circus Bavarian without demanding significant changes?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    The short answer is a new board of directors. The current board is not perceived as trustworthy. They are perceived as bandits in suits.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Agreed. Incomprehensible that we as shareholders apparently are powerless!
  • 9.12. · Muokattu
    ·
    9.12. · Muokattu
    ·
    New variant of mpox found ( https://news.sky.com/story/new-mpox-strain-discovered-in-england-13480985 ). This certainly does not mean that it is worse or more contagious than existing variants - it could easily be less harmful. But it probably reminds governments around the world that there is a clear risk that a new variant could lead to a new epidemic, so it's a good idea to have some vaccine in stock (a new variant can of course be immune to the vaccine, but since the vaccine is so broad that it protects against both smallpox and mpox, it is probably likely that it will protect against new mpox variants.)
    9.12. · Muokattu
    ·
    9.12. · Muokattu
    ·
    It's only a matter of time before Mother Earth hits the truly evil variant, as long as local vaccination is lacking in areas where the virus is endemic. Every time the virus infects a new person, it's a new ticket in the lottery for mutations. Our best common defense will be to ask local populations to take the vaccine "for the team" and then ourselves be willing to pay for the international effort.
    3 päivää sitten
    ·
    3 päivää sitten
    ·
    Mpox is a DNA virus, unlike, for example, covid, which is an RNA virus, which means it mutates much less, so it is certainly far from certain that it will mutate into something truly serious in the next many, many years despite its presence in humans – fortunately, because we only have to look at its cousin: the smallpox virus to see how serious it can become if viruses in this family truly become dangerous.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti
29 päivää sitten45 min

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    When will the offer of 270 kr. come, which ATP assessed to be an appropriate level for the share when the company was to be sold? The price has been around 190 +/- for almost a month after the rejection of 250 kr.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Well, but if many small shareholders like us contact them, it can also make an impression.
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    It's absolutely incredible what one can read, here from an article in Medwatch: "CEO Paul Chaplin believes in market support if the company needs new capital raising for future acquisitions." Bavarian has currently initiated an acquisition program for 500 mio., and at the same time, the CEO is apparently toying with the idea of capital raising for acquisitions. So the money being paid out to shareholders now, the company might ask to get back later It's of course great for the financial institutions and SKAT that part of the 500 mio. from the acquisition program ends up with them, but where is the consideration for the shareholders??? Just sell that junk.
    1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Johse Share buybacks are for "treasury", if you read the communication from Bavarian. The capital is therefore NOT distributed further to the shareholders but is held by the company. Please ask if you want a more detailed explanation before you draw any wrong conclusions with "payout" and "tax".
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    The criticism below of Bavarian and ATP you should direct towards yourselves. Now be an adult. It is solely us as shareholders who are responsible for our investments, and we should have sold at 230-250 when the opportunity was there.. If we do not trust the company's management or its major shareholder, then we must find something else to invest in. Bavarian's management has always been incompetent, overly optimistic, and untrustworthy. The major shareholder's task is not to look after our interests (that is solely our own task), but his task is to look after the interests of the employees/trade union movement.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Which criticism below, Johse?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Wouldn't it be more relevant to place your "general" criticism in the respective thread another time, instead of arguing into thin air?
  • 2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    Nice to see ATP as a "critical" shareholder and again positive towards Bavarian's management. ATP proves once again to be completely useless as a shareholder, to put its foot down and exercise its power over the management. What does the army in here think, who during the process were positive about ATP's abilities and their no to a sale. Did you expect that ATP would subsequently explicitly support the management and again be positive about circus Bavarian without demanding significant changes?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    The short answer is a new board of directors. The current board is not perceived as trustworthy. They are perceived as bandits in suits.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Agreed. Incomprehensible that we as shareholders apparently are powerless!
  • 9.12. · Muokattu
    ·
    9.12. · Muokattu
    ·
    New variant of mpox found ( https://news.sky.com/story/new-mpox-strain-discovered-in-england-13480985 ). This certainly does not mean that it is worse or more contagious than existing variants - it could easily be less harmful. But it probably reminds governments around the world that there is a clear risk that a new variant could lead to a new epidemic, so it's a good idea to have some vaccine in stock (a new variant can of course be immune to the vaccine, but since the vaccine is so broad that it protects against both smallpox and mpox, it is probably likely that it will protect against new mpox variants.)
    9.12. · Muokattu
    ·
    9.12. · Muokattu
    ·
    It's only a matter of time before Mother Earth hits the truly evil variant, as long as local vaccination is lacking in areas where the virus is endemic. Every time the virus infects a new person, it's a new ticket in the lottery for mutations. Our best common defense will be to ask local populations to take the vaccine "for the team" and then ourselves be willing to pay for the international effort.
    3 päivää sitten
    ·
    3 päivää sitten
    ·
    Mpox is a DNA virus, unlike, for example, covid, which is an RNA virus, which means it mutates much less, so it is certainly far from certain that it will mutate into something truly serious in the next many, many years despite its presence in humans – fortunately, because we only have to look at its cousin: the smallpox virus to see how serious it can become if viruses in this family truly become dangerous.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
69 002
Myynti
Määrä
69 035

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
8--
76--
1 939--
948--
152--
Ylin
191,95
VWAP
189,04
Alin
187,55
VaihtoMäärä
66,3 350 659
VWAP
189,04
Ylin
191,95
Alin
187,55
VaihtoMäärä
66,3 350 659

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4 -tulosraportti
12.3.2026
Menneet tapahtumat
2025 Q3 -tulosraportti14.11.
2025 Q2 -tulosraportti26.8.
2025 Q1 -tulosraportti9.5.
2024 Q4 -tulosraportti5.3.
2024 Q3 -tulosraportti15.11.2024
Datan lähde: FactSet, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti
29 päivää sitten45 min

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4 -tulosraportti
12.3.2026
Menneet tapahtumat
2025 Q3 -tulosraportti14.11.
2025 Q2 -tulosraportti26.8.
2025 Q1 -tulosraportti9.5.
2024 Q4 -tulosraportti5.3.
2024 Q3 -tulosraportti15.11.2024
Datan lähde: FactSet, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    When will the offer of 270 kr. come, which ATP assessed to be an appropriate level for the share when the company was to be sold? The price has been around 190 +/- for almost a month after the rejection of 250 kr.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Well, but if many small shareholders like us contact them, it can also make an impression.
  • 1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    It's absolutely incredible what one can read, here from an article in Medwatch: "CEO Paul Chaplin believes in market support if the company needs new capital raising for future acquisitions." Bavarian has currently initiated an acquisition program for 500 mio., and at the same time, the CEO is apparently toying with the idea of capital raising for acquisitions. So the money being paid out to shareholders now, the company might ask to get back later It's of course great for the financial institutions and SKAT that part of the 500 mio. from the acquisition program ends up with them, but where is the consideration for the shareholders??? Just sell that junk.
    1 päivä sitten · Muokattu
    ·
    1 päivä sitten · Muokattu
    ·
    Johse Share buybacks are for "treasury", if you read the communication from Bavarian. The capital is therefore NOT distributed further to the shareholders but is held by the company. Please ask if you want a more detailed explanation before you draw any wrong conclusions with "payout" and "tax".
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    The criticism below of Bavarian and ATP you should direct towards yourselves. Now be an adult. It is solely us as shareholders who are responsible for our investments, and we should have sold at 230-250 when the opportunity was there.. If we do not trust the company's management or its major shareholder, then we must find something else to invest in. Bavarian's management has always been incompetent, overly optimistic, and untrustworthy. The major shareholder's task is not to look after our interests (that is solely our own task), but his task is to look after the interests of the employees/trade union movement.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Which criticism below, Johse?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Wouldn't it be more relevant to place your "general" criticism in the respective thread another time, instead of arguing into thin air?
  • 2 päivää sitten · Muokattu
    ·
    2 päivää sitten · Muokattu
    ·
    Nice to see ATP as a "critical" shareholder and again positive towards Bavarian's management. ATP proves once again to be completely useless as a shareholder, to put its foot down and exercise its power over the management. What does the army in here think, who during the process were positive about ATP's abilities and their no to a sale. Did you expect that ATP would subsequently explicitly support the management and again be positive about circus Bavarian without demanding significant changes?
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    The short answer is a new board of directors. The current board is not perceived as trustworthy. They are perceived as bandits in suits.
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    Agreed. Incomprehensible that we as shareholders apparently are powerless!
  • 9.12. · Muokattu
    ·
    9.12. · Muokattu
    ·
    New variant of mpox found ( https://news.sky.com/story/new-mpox-strain-discovered-in-england-13480985 ). This certainly does not mean that it is worse or more contagious than existing variants - it could easily be less harmful. But it probably reminds governments around the world that there is a clear risk that a new variant could lead to a new epidemic, so it's a good idea to have some vaccine in stock (a new variant can of course be immune to the vaccine, but since the vaccine is so broad that it protects against both smallpox and mpox, it is probably likely that it will protect against new mpox variants.)
    9.12. · Muokattu
    ·
    9.12. · Muokattu
    ·
    It's only a matter of time before Mother Earth hits the truly evil variant, as long as local vaccination is lacking in areas where the virus is endemic. Every time the virus infects a new person, it's a new ticket in the lottery for mutations. Our best common defense will be to ask local populations to take the vaccine "for the team" and then ourselves be willing to pay for the international effort.
    3 päivää sitten
    ·
    3 päivää sitten
    ·
    Mpox is a DNA virus, unlike, for example, covid, which is an RNA virus, which means it mutates much less, so it is certainly far from certain that it will mutate into something truly serious in the next many, many years despite its presence in humans – fortunately, because we only have to look at its cousin: the smallpox virus to see how serious it can become if viruses in this family truly become dangerous.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
69 002
Myynti
Määrä
69 035

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
8--
76--
1 939--
948--
152--
Ylin
191,95
VWAP
189,04
Alin
187,55
VaihtoMäärä
66,3 350 659
VWAP
189,04
Ylin
191,95
Alin
187,55
VaihtoMäärä
66,3 350 659

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt